The Coronavirus Test Kits Market in Europe is expected to grow at a CAGR of -9.83% to reach USD -8 billion by 2028. The emergence of various SARS-CoV-2 virus lineages, some of which have been categorized as variants of concern by the World Health Organization (WHO), is leading to increased demand for coronavirus test kits in Europe. These variants, such as BA.2 or stealth omicron, have shown increased transmissibility and potential for altered symptom severity. As vaccination campaigns continue and populations receive booster doses, the growth rate of the coronavirus test kits market in Europe may moderate, but the ongoing need for regular testing will ensure continued demand.
Europe dominates the regional market because of The European Coronavirus Test Kits market is experiencing significant growth due to the ongoing pandemic. Companies are ramping up production to meet surging demand for diagnostic tools. Key players include Roche, Thermo Fisher Scientific, and Abbott, who are leveraging advanced technologies to deliver accurate results. Regulatory approvals and strategic collaborations are also driving market expansion. This trend is expected to continue as Europe works to contain the spread of COVID-19.
There are various factors that drive the Coronavirus Test Kits Market in Europe market which are as following: In response to the saturation of European healthcare systems due to escalating patient demands for intensive care, governments have prioritized enhancing mass testing capabilities. This has led to the distribution of coronavirus home testing kits across the region in 2022. The European Commission has curated a comprehensive list of antigen tests, ensuring the availability of dependable testing solutions. Furthermore, the Joint Research Centre (JRC) has established a database comprising information on over 2600 coronavirus test devices and methods, making it a globally renowned inventory.
Be the first one to get the industry updates. Request for a sample report
Coronavirus Test Kits Market in Europe Segmentation
End-user (Government, Non government) Type (Rapid test kit, RT-PCR, Others) Geography (Europe)
The market witnesses several challenges, which are as follows The European market for coronavirus test kits has experienced significant growth due to the urgent demand for rapid diagnostic solutions. However, the accuracy and consistency of test results remain critical concerns. Inaccurate test outcomes, including false negatives and false positives, can lead to misdiagnosis and hinder effective disease management. Regulatory bodies are working to establish guidelines for testing procedures, while countries like Spain have relied on imports from China for testing equipment. However, the use of certain imported test kits has revealed low sensitivity rates, with only 30% of patients with the SARS-CoV-2 virus being correctly identified. Ensuring the highest level of test accuracy is essential to mitigate potential health risks and maintain public trust.
Stay ahead of your competitors. Download the Free PDF report
Some of the key companies that have been profiled in the report include:
The global healthcare supplies market encompasses businesses and innovators involved in the research and development of a wide range of medical consumables, including diagnostic and therapeutic products. According to Technavio, the market size is determined by the consolidated revenue generated by manufacturers of medical supplies such as syringes, drapes, gloves, and gowns. Factors fueling growth in the healthcare supplies sector include an aging population, with the global population aged 60 and above projected to reach nearly one-quarter by 2050 in the US and Europe reaching a similar demographic milestone by 2030. - The Coronavirus Test Kits Market in Europe is experiencing significant growth, fueled by the Rising adoption of rapid coronavirus test kits. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
The Coronavirus Test Kits market in Europe has seen a significant surge due to the emergence of new variants like Omicron and Delta. Max Healthcare and ICMR are some of the key players in Europe supplying RT-PCR test kits for the detection of SARS-CoV-2, the virus that causes COVID-19. These tests are crucial for early detection and isolation of infected individuals to prevent the spread of the virus in communities. User-friendly PoC (Point of Care) kits are gaining popularity due to their rapid screening capabilities, making it easier for healthcare systems to conduct tests in various settings. The tests involve the collection of human nasal samples and the detection of viral genetic material using RT-PCR technology or SARS-CoV-2 antigen. According to the Medical Device database by GlobalData, major companies like Roche are also investing in the development of rapid and accurate test kits for the detection of the virus. The use of RT-PCR tests, which identify the presence of the virus by detecting its RNA, remains the gold standard for COVID-19 testing. The European market for Coronavirus Test Kits is expected to continue growing as the need for regular testing persists to manage the ongoing pandemic.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
